Pooled CRISPRi screening reveals fungal-specific vulnerabilities across environments and genetic backgrounds
Wensing, L.; Despres, P.; Francis, D.; Fogal, M.; Hendriks, A.; Gervais, N.; Fikry, C.; Adamu Bukari, A.-R.; Gerstein, A.; Cuomo, C. A.; Shapiro, R. S.
Show abstract
The rising rate of drug-resistant fungal infections and the emergence of fungal pathogens with intrinsic resistance phenotypes are a growing concern. The close evolutionary distance between mammals and fungi complicates the design of new antifungals and increases the chances of toxic off-target effects. As such, antifungal drug development usually focuses on fungal-specific proteins when considering potential new targets. Ideal drug targets should mediate essential cell processes and be highly sensitive to inhibition. Targeted gene repression can serve as a model for drug-mediated inhibition and for determining the dosage-sensitivity profile of genes of interest. In the fungal pathogen Candida albicans, classical approaches for gene repression can be labour-intensive and limited to one genetic background due to low throughput. Here, we adapt pooled CRISPRi screening in C. albicans for the first time and exploit this technique for large-scale functional genomic analysis. Through pooled CRISPRi screening, we test the repression sensitivity of over a hundred essential genes conserved in fungi but absent in humans, and successfully identify highly dosage-sensitive genes across multiple cell components and pathways. By extending our analysis to ten diverse environmental conditions, we show how the environment influences dosage-sensitivity profiles. Finally, we extend our experiments to two clinical drug-resistant C. albicans strain backgrounds and demonstrate that many of the fitness defects we observed are conserved in resistant clinical isolates. Together, our results highlight a set of genes that are highly dosage-sensitive across different genetic and environmental contexts, making them attractive targets for further investigation. By facilitating rapid, efficient large-scale functional genomics assays across diverse genetic backgrounds, CRISPRi pooled screening will open new frontiers in C. albicans biology.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to anti-fungal compounds 96%
- Arrayed CRISPRi and Quantitative Imaging Describe the Morphotypic Landscape of Essential Mycobacterial Genes 96%
- Obligate sexual reproduction of a homothallic fungus closely related to the Cryptococcus pathogenic species complex 95%
Similar papers in this journal
- A large European diversity panel reveals complex azole fungicide resistance gains of a major wheat pathogen 95%
- Antifungal tolerance and resistance emerge at distinct drug concentrations and rely upon different aneuploid chromosomes 94%
- Resistance-guided mining of bacterial genotoxins defines a family of DNA glycosylases 94%
Similar papers in this journal
- Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium 95%
- CRISPR-Cas12a induced DNA double-strand breaks are repaired by locus-dependent and error-prone pathways in a fungal pathogen 94%
- Perturbing proteomes at single residue resolution using base editing 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.